4Carrazana El,Mikoshiba I. Rationale and evidence for the use ofoxcarbazepine in neuropathic pain [ J]. J Pain Symptom Manage,2003, 25:S31 -S35.
5Ahmad B, Dieter S, Joseph D. Oxcarbazepine versus carbamazepinein trigeminal neuralgia : a meta - analysis of three double - blindcomparative trails [ EB/OL ]. http://wenku. baidu. com/view/d9cf8508ddccda38366baf50. html,2014- 12 -03.
6Wei CY, Ko TM, Shen CY fet al. A recent update of pharmacog-enomics in drug induced severe skin reactions [ J ]. Drug MetabPharmacokinet,2012 ;27 : 132 - 141.
7Chung WH, Hung SI, Hong HS, et al. Medical genetics: a markerfor Stevens - Johnson syndrome[ J] . Nature, 2004 , 428 : 486.
8Lv YD, Min FL, Liao WP, et al. The association between oxcarba-zepine induced maculopapular eruption and HLA - B alleles in anorthern Han Chinese populationf J]. BMC Neurol, 2013,13:75.
10T. P. Jorns,J. M. Zakrzewska.??Evidence-based approach to the medical management of trigeminal neuralgia(J)British Journal of Neurosurgery . 2007 (3)
